Outcome Measurement for Mental Health and Addiction Services

Why This Matters Now

Routine outcome measurement used to be the preserve of NHS Talking Therapies (formerly IAPT) and academic services. That has changed. Major UK insurers now expect outcome data to evidence clinical effectiveness. NHS commissioners ask for it during procurement. NICE Evidence Standards Framework treats it as table stakes for digital mental health products. And patients themselves are more sophisticated, often asking before they book how a service measures progress.

The good news is that the UK has unusually well-validated, freely available outcome measures suitable for almost every mental health and addiction setting. The bad news is that most private services either do not use them or use them as a discharge formality that adds nothing to clinical work. Done well, routine outcome measurement improves outcomes, retention, and clinician satisfaction. Done badly, it is paperwork everyone resents.

The Mental Health Measure Stack

For adult mental health work in the UK, three measures form a strong baseline: CORE-OM, PHQ-9, and GAD-7. Together they give you broad psychological distress, depression severity, and anxiety severity, in measures that referrers, insurers, and patients all recognise.

CORE-OM (and CORE-10)

The Clinical Outcomes in Routine Evaluation Outcome Measure is a 34-item self-report measure developed at the University of Leeds for use across the full range of adult psychological therapy. CORE-10 is the brief version designed for session-by-session use.

Validated extensively in UK populations and recommended by the British Association for Counselling and Psychotherapy. Free for clinical use through the CORE System Trust. Cut-offs and reliable change indices are published.

PHQ-9

The Patient Health Questionnaire 9-item depression scale. Nine items mapped directly to DSM criteria for major depression, with established cut-offs for symptom severity (none, mild, moderate, moderately severe, severe).

UK validated for primary care and routine clinical use. Used universally in NHS Talking Therapies. Free for use without a fee. Excellent for tracking depression severity session by session.

GAD-7

The Generalised Anxiety Disorder 7-item scale. Brief, well-validated measure of generalised anxiety symptoms with established severity cut-offs.

Companion to PHQ-9, also free, also used universally in NHS Talking Therapies. PHQ-9 and GAD-7 together are a defensible minimum dataset for any service treating common mental health conditions.

Specialist services add condition-specific measures. PCL-5 for PTSD. EDE-Q for eating disorders. OCI-R for OCD. YBOCS for severe OCD. The Edinburgh Postnatal Depression Scale for perinatal mental health. Add only what informs your clinical decisions; the goal is signal, not paperwork.

The Addiction Measure Stack

UK addiction services have a slightly different evidence base, anchored by the Treatment Outcomes Profile and screening instruments validated by the World Health Organization.

AUDIT

The Alcohol Use Disorders Identification Test. WHO-developed 10-item screen with validated cut-offs for hazardous, harmful, and dependent drinking. AUDIT-C is the brief 3-item version useful for triage.

DUDIT

The Drug Use Disorders Identification Test. Companion screen to AUDIT covering non-alcohol substance use. Useful for assessment and re-assessment, particularly in services where polydrug use is common.

Treatment Outcomes Profile (TOP)

The standard outcome instrument for the National Drug Treatment Monitoring System (NDTMS). Captures substance use, injecting risk behaviours, crime, health, and social functioning. Mandatory for commissioned services and a sensible standard for any UK addiction service that wants comparable benchmarking.

Severity of Dependence Scale and SADQ

The Severity of Dependence Scale for general substance dependence, and the Severity of Alcohol Dependence Questionnaire for alcohol-specific assessment. Useful clinically for treatment planning and monitoring change.

Frequency: How Often Is Enough?

Frequency depends on intensity of treatment. For session-by-session talking therapy, brief measures like CORE-10 administered every session work well and mirror NHS Talking Therapies practice. For lower-intensity or longer-term work, monthly or every-fourth-session measurement is more sustainable. For addiction treatment, TOP is typically completed at treatment start, every 6 months, and at discharge or transfer.

The principle is that measures should inform the clinical work in real time. If a score moves significantly between sessions, that is a clinical event worth discussing with the patient. If a score plateaus, that is a prompt to review the formulation. Outcome measurement that sits in a database without entering the consulting room is wasted effort.

Operational Implementation

The practical challenge is workflow, not the measures. The clinics that get this right share a few characteristics. They administer measures digitally before sessions, so completion does not eat session time. They show clinicians the score and trend at the start of each session, ideally graphically. They train clinicians to discuss scores with patients, not just file them. And they review outcome data at supervision and team level, not just patient level.

Most modern mental health EHRs include outcome measure delivery as a native feature. Where they do not, dedicated tools like PCMIS or Iaptus integrate well. Avoid spreadsheet workflows. They look cheap until you cost in clinician time and broken data.

Reporting and Benchmarking

Once you collect outcome data, use it. Service-level reporting should cover: percentage of patients with complete pre and post measures, average effect size by clinician and condition, reliable change rates, recovery rates against published benchmarks, and dropout patterns.

For mental health, the NHS Talking Therapies dataset gives a useful national benchmark. For addiction services, NDTMS provides comparator data. Insurers often share their own benchmarks during contracting discussions. Use these comparisons sparingly and honestly, particularly when patient mix differs.

Clinical Governance Implications

Routine outcome measurement strengthens almost every aspect of clinical governance. It feeds supervision, gives early warning of clinician drift, supports CQC evidence of clinical effectiveness, and provides the comparative data needed for serious incident reviews. Outcome measurement does not replace clinical judgement, but it does triangulate it. Our clinical governance guide covers how this fits into a broader quality framework.

Common Mistakes

• Using too many measures. Pick a defensible minimum set and use it consistently.
• Treating measures as paperwork. If you do not look at the score in session, do not collect it.
• Comparing to inappropriate benchmarks. Patient mix, severity, and pathway all matter.
• Ignoring missing data. High dropout in measurement usually predicts high dropout in treatment.
• Failing to act on individual deterioration. Significant negative change is a safety signal.

We help mental health and addiction services design and implement outcome frameworks that add clinical and commercial value. If you are starting from scratch or want to upgrade your current setup, our practice optimisation work covers exactly this.

Frequently Asked Questions

Which outcome measure should I use as a private therapist?

For most adult mental health work, CORE-OM (or its short form CORE-10) plus PHQ-9 and GAD-7 covers 80 per cent of presentations. CORE gives you a broad measure of psychological distress validated for routine clinical use. PHQ-9 and GAD-7 give you condition-specific scores for depression and anxiety that insurers and referrers recognise. For addiction services, AUDIT for alcohol, DUDIT for drugs, and the Treatment Outcomes Profile (TOP) for general substance misuse outcomes are the practical baseline.

How often should I administer outcome measures?

Session-by-session works well in talking therapies, particularly with CORE-10 or short PHQ-9 versions, and is the model used in NHS Talking Therapies. For lower-intensity or longer-term work, every fourth session or monthly is more practical. The principle is that measures should inform the work in real time, not gather dust until discharge. For addiction services, TOP is typically administered at start of treatment, every 6 months, and at discharge or transfer.

Will patients tolerate routine outcome measurement?

Yes, when it is presented as a clinical tool rather than admin. Most patients value seeing their progress quantified, and clinicians who use measures collaboratively report better engagement, not worse. The key is to discuss results with the patient in session, not just file them. Brief measures like PHQ-9, GAD-7, and CORE-10 take under three minutes to complete.

Do private patients and insurers expect outcome data?

Increasingly, yes. Major UK insurers including Bupa, AXA Health, Aviva, and Vitality now ask providers to demonstrate clinical effectiveness. Some pathways, particularly stepped care for common mental health conditions, now require pre and post outcome data. Self-pay patients are also more sophisticated than they used to be and often ask how outcomes are measured. Routine outcome measurement is becoming a competitive differentiator, not just a clinical tool.

Are there licensing or copyright restrictions on these measures?

It varies. PHQ-9 and GAD-7 are free for clinical and educational use under the original copyright held by Pfizer (PHQ-9) with no fee required. CORE-OM and CORE-10 are free for clinical use through the CORE System Trust but require attribution and are not to be modified. AUDIT is published by the World Health Organization and free for non-commercial use. The Treatment Outcomes Profile (TOP) is freely available through the National Drug Treatment Monitoring System for use in commissioned addiction services. Always check the current licensing position before embedding measures in commercial software.